Samsung Biologics Co.,Ltd. (KRX: 207940)
South Korea
· Delayed Price · Currency is KRW 937,000
-20,000 (-2.09%)
Nov 15, 2024, 3:30 PM KST
Samsung Biologics Co.,Ltd. Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 1,028,404 | 857,691 | 798,056 | 393,589 | 240,975 | 202,904 | Upgrade
|
| Depreciation & Amortization | 571,932 | 489,782 | 308,264 | 161,789 | 143,688 | 132,885 | Upgrade
|
| Loss (Gain) From Sale of Assets | 4,168 | 3,866 | 2,588 | 7,466 | 1,841 | 806.21 | Upgrade
|
| Asset Writedown & Restructuring Costs | 731.08 | - | - | 725.89 | 1,352 | -1,904 | Upgrade
|
| Loss (Gain) From Sale of Investments | -5,069 | -5,152 | -72,653 | -269.12 | -303.96 | -407.22 | Upgrade
|
| Loss (Gain) on Equity Investments | 275.57 | 499.42 | -27,260 | -13,853 | 17,768 | -72,940 | Upgrade
|
| Provision & Write-off of Bad Debts | 27,965 | 21,511 | 22,407 | 4,857 | - | - | Upgrade
|
| Other Operating Activities | 87,830 | -711.89 | 185,130 | 135,132 | 304.75 | -63,305 | Upgrade
|
| Change in Accounts Receivable | -333,931 | 30,127 | -305,336 | -120,660 | -61,480 | -69,001 | Upgrade
|
| Change in Inventory | -278,291 | -273,896 | -179,912 | -370,571 | -184,885 | -156,325 | Upgrade
|
| Change in Accounts Payable | 227,149 | 267,037 | 134,594 | 21,060 | 58,253 | 1,461 | Upgrade
|
| Change in Unearned Revenue | 130,914 | 27,199 | 44,017 | - | - | - | Upgrade
|
| Change in Other Net Operating Assets | 191,495 | 248,276 | 43,151 | 235,330 | -15,422 | 35,978 | Upgrade
|
| Operating Cash Flow | 1,653,573 | 1,666,229 | 953,048 | 454,596 | 202,090 | 10,154 | Upgrade
|
| Operating Cash Flow Growth | 27.41% | 74.83% | 109.65% | 124.95% | 1890.33% | - | Upgrade
|
| Capital Expenditures | -589,356 | -995,071 | -956,840 | -406,254 | -139,665 | -192,838 | Upgrade
|
| Sale of Property, Plant & Equipment | 169.87 | 2,811 | 64.01 | 37.64 | 47.69 | 42.33 | Upgrade
|
| Cash Acquisitions | -601,956 | -1,071,525 | -1,081,821 | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | -103,505 | -110,254 | -52,386 | -14,898 | -8,901 | -9,462 | Upgrade
|
| Investment in Securities | 740,484 | 607,760 | -1,015,673 | -512,375 | -270,167 | 541,899 | Upgrade
|
| Other Investing Activities | 0 | 0 | 178.52 | -0 | - | - | Upgrade
|
| Investing Cash Flow | -554,164 | -1,566,305 | -3,106,477 | -933,489 | -418,686 | 339,642 | Upgrade
|
| Short-Term Debt Issued | - | 758,500 | 593,750 | 50,000 | 30,000 | 150,000 | Upgrade
|
| Long-Term Debt Issued | - | 45,000 | 211,903 | 648,356 | 499,952 | - | Upgrade
|
| Total Debt Issued | 716,500 | 803,500 | 805,653 | 698,356 | 529,952 | 150,000 | Upgrade
|
| Short-Term Debt Repaid | - | -686,783 | -496,988 | -30,000 | -150,000 | -90,000 | Upgrade
|
| Long-Term Debt Repaid | - | -751,967 | -496,906 | -171,734 | -257,392 | -299,806 | Upgrade
|
| Total Debt Repaid | -1,416,227 | -1,438,750 | -993,894 | -201,734 | -407,392 | -389,806 | Upgrade
|
| Net Debt Issued (Repaid) | -699,727 | -635,250 | -188,241 | 496,622 | 122,560 | -239,806 | Upgrade
|
| Issuance of Common Stock | - | - | 3,200,751 | - | - | - | Upgrade
|
| Other Financing Activities | 200 | 200 | -12,430 | -0 | 0 | - | Upgrade
|
| Financing Cash Flow | -699,647 | -635,050 | 3,000,080 | 496,622 | 122,560 | -239,806 | Upgrade
|
| Foreign Exchange Rate Adjustments | 38,930 | 12,245 | -3,242 | 831.1 | -2,215 | -2,511 | Upgrade
|
| Net Cash Flow | 438,692 | -522,882 | 843,409 | 18,560 | -96,251 | 107,479 | Upgrade
|
| Free Cash Flow | 1,064,217 | 671,158 | -3,792 | 48,343 | 62,425 | -182,684 | Upgrade
|
| Free Cash Flow Growth | 376.10% | - | - | -22.56% | - | - | Upgrade
|
| Free Cash Flow Margin | 25.27% | 18.17% | -0.13% | 3.08% | 5.36% | -26.04% | Upgrade
|
| Free Cash Flow Per Share | 14952.33 | 9429.82 | -54.32 | 730.64 | 943.48 | -2761.04 | Upgrade
|
| Cash Interest Paid | 55,379 | 63,486 | 33,940 | 18,594 | 15,630 | 26,345 | Upgrade
|
| Cash Income Tax Paid | 288,424 | 319,321 | 188,473 | 42,369 | 38,429 | 42,105 | Upgrade
|
| Levered Free Cash Flow | 525,972 | -446,653 | 21,978 | 62,860 | 41,358 | -262,782 | Upgrade
|
| Unlevered Free Cash Flow | 566,830 | -395,655 | 62,019 | 72,052 | 51,411 | -246,772 | Upgrade
|
| Change in Net Working Capital | 139,934 | 476,162 | -148,213 | 4,403 | 126,702 | 234,697 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.